Delivery Order SPE2DR25D1205-SPE2DR26F0WP0
- Not listed
- The Defense Logistics Agency awarded a $1,659.99 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Pirfenidone 267 mg tablets (90-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of November 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,345.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Pirfenidone 267 mg, with performance in Conshohocken, Pennsylvania and completion by September 5, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, fulfilling the federal government's medical procurement needs for this specialty pharmaceutical...
- The Defense Logistics Agency awarded a $3,689.04 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Pirfenidone 801 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $38,274.47 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Pirfenidone 267 mg tablets (270-count units). This competitively awarded, firm fixed price contract carries an ultimate completion date of November 14, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $1,361.08 delivery order to AmerisourceBergen Drug Corp for Pirfenidone 801 mg tablets (90-count supply) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed at the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pirfenidone 267 mg tablets (90-count supply) under a firm fixed price contract valued at $46,234.38. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Pirfenidone is an antifibrotic agent commonly used in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,218.52 delivery order on July 10, 2025, for the supply of Pirfenidone 801 mg tablets (90-count units). This firm fixed price contract, which has no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pirfenidone 801 mg tablets (90-count units) under a firm fixed-price contract valued at $2,766.77. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,382.08 for 90-count tablets of Pirfenidone 801 mg on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price, competitively awarded contract requires performance at the vendor's Conshohocken, Pennsylvania location. The delivery order was issued without a set-aside designation, reflecting AmerisourceBergen's competitive standing as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pirfenidone 267 mg capsules (270-count units) with a ceiling value of $5,487.30. This competitive, non-set-aside delivery order operates under a firm fixed price structure with an ultimate completion date of July 15, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WP0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Pirfenidone 267 mg tablets (270-count) valued at $39,975.34. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements in the pharmaceutical supply market. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. Pirfenidone is an antifibrotic medication primarily used in the treatment of idiopathic pulmonary fibrosis, reflecting the breadth of specialty pharmaceutical products delivered through the company's federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 11/12/25 |